We identified 7,511 individuals who used GLP-1 RAs and did not undergo dialysis or die within 3 months post-discharge were enrolled as the GLP-1 RAs users group (Table 1)
Animal studies have suggested that there are potential risks to using Ozempic around pregnancy
This precision approach avoids unnecessary supplementation and focuses resources on interventions most relevant to your oxidative stress burden and metabolic capacity
Leah Liszak, Meghan Etsey, Yun Weisholtz, MD-PhD on behalf of AMWA Gender Equity Task Force Diabetes care has entered an era of precision therapeutics: we no longer treat blood sugar as a single entity but rather tailor regimens to comorbidities, risk profiles, and, critically, individual biology
In 2023, these states spent the least on GLP-1 weight loss drugs (in millions), in ascending order: Wyoming with $66 million